Kymab VP Paul Kellam evidence to House of Lords

Professor Paul Kellam

Source: Kymab

Professor Kellam provides evidence to UK's House of Lords Science and Technology Committee review of Life Sciences and the UK Industrial Strategy

Professor Paul Kellam, Kymab’s Vice-President of Infectious Disease and Vaccines, provided evidence at the House of Lords Science and Technology Committee’s inquiry on Life Sciences and the Industrial Strategy.

The evidence session, at 10.00 am on Tuesday 16 January, 2018, is available to view or to download as audio from

Professor Kellam represented the Microbiology Society before the Committee. Topics planned for review included: the January 2017 Green Paper ‘Building our industrial strategy’; the definition of life sciences in this context; the influence of Brexit in the life science sector.

Find out which events we'll be attending this year

View events